New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 7, 2014
07:10 EDTNEONeoGenomics validates and launches new detection test for the CALR gene
NeoGenomics announced that it has validated and launched a new test for the detection of mutations in the calreticulin, or CALR, gene. The CALR gene is a novel biomarker that was reported to be specific for myeloproliferative neoplasms for the first time at the annual meeting of the American Society of Hematology last month. Since then, findings on the CALR gene have been published in the three articles referenced below.
News For NEO From The Last 14 Days
Check below for free stories on NEO the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
August 15, 2014
08:41 EDTNEONeoGenomics 7M share Spot Secondary priced at $4.60
The deal size was increased to 7M shares from 5M shares and was priced at $4.60. William Blair acted as lead book running manager for the offering.
August 14, 2014
16:02 EDTNEONeoGenomics files to sell common stock, no amount given
NeoGenomics anticipates using the net proceeds from the offering for working capital, capital expenditures and other corporate purposes, including potential acquisitions and the repayment of debt. William Blair & Company, L.L.C. is the sole book-running manager and Craig-Hallum Capital Group LLC is co-lead manager for the offering. Stephens Inc., Roth Capital Partners, LLC, Sidoti & Company, LLC and Dawson James Securities, Inc. are serving as co-managers for the offering.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use